| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/14/2008 | WO2008017852A1 Diamine-containing, tetra- substituted piperazine compounds as melanocortin receptor modulators |
| 02/14/2008 | WO2008002245A3 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 02/14/2008 | WO2008002244A3 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 02/14/2008 | WO2007139955A8 Triazole compounds that modulate hsp90 activity |
| 02/14/2008 | WO2007136302A3 Active substances, pharmaceutical composition and a method for the production and use thereof |
| 02/14/2008 | WO2007130780A3 Benzimidazole modulators of vr1 |
| 02/14/2008 | WO2007083017A3 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/14/2008 | US20080039630 Cyanine compounds and their application as quenching compounds |
| 02/14/2008 | US20080039622 2,4-pyrimidinediamine compounds and their uses |
| 02/14/2008 | US20080039501 Hydrate forms of amg706 |
| 02/14/2008 | US20080039479 Compounds and therapeutical use thereof |
| 02/14/2008 | US20080039472 Inhibitors of the Interaction Between Mdm2 and P53 |
| 02/14/2008 | US20080039465 Triazolyl phenyl benzenesulfonamides |
| 02/14/2008 | US20080039462 Compounds having 5-HT6 receptor affinity |
| 02/14/2008 | US20080039450 Compounds |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 02/14/2008 | US20080039446 Substituted isoindoles and their use |
| 02/14/2008 | US20080039445 Production method of pyrimidine compounds |
| 02/14/2008 | US20080039440 such as 6-(6-Amino-pyrimidin-4-yloxy)-3,4-dihydro-2H-quinoline-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide, used for the treatment of leukemia |
| 02/14/2008 | US20080039437 New Pyridine Analogues III |
| 02/14/2008 | US20080039327 3-heterocyclyl-substituted benzoyl derivatives |
| 02/14/2008 | US20080038213 1,3-Bis-[3-(4-methoxyphenyl)-2-propenoyloxy]-2-oxopropane; novel alpha-hydroxyketone derivatives as light-protection filters for cosmetic or drug products; used in cosmetic protective coatings; solar radiation; sunscreen agents; aging resistance; wrinkle resistance; food additives; dermatology |
| 02/14/2008 | US20080036373 Platinum complex and light-emitting device |
| 02/14/2008 | DE102006037478A1 2-(Heterocyclylbenzyl)-pyridazinonderivate 2- (Heterocyclylbenzyl) -pyridazinone derivatives |
| 02/14/2008 | CA2659894A1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| 02/13/2008 | EP1887004A1 Crystalline forms of (1R,2R)-7-Chloro-3-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]quinazolin-4(3H)-one |
| 02/13/2008 | EP1887003A1 3-[4-heterocyclyl -1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| 02/13/2008 | EP1885714A2 Process for the preparation of 2-alkyl-1-((2'-substituted-biphenyl-4-yl)methyl)-imidazole, dihydroimidazole or benzimidazole derivatives |
| 02/13/2008 | EP1885713A1 1, 2, 4 -triazole derivatives as vasopressin antagonists |
| 02/13/2008 | EP1885695A2 Novel indoline compounds |
| 02/13/2008 | EP1885486A1 Affinity adsorbents for factor viii and von willebrand's factor |
| 02/13/2008 | EP1885375A1 Novel nsaids possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 02/13/2008 | EP1335908B1 Peroxisome proliferator activated receptor alpha agonists |
| 02/13/2008 | CN101124201A Parp抑制剂 Parp inhibitors |
| 02/13/2008 | CN101123962A 可诱导一氧化氮合成酶二聚化的抑制剂 Inducible nitric oxide synthase dimerization inhibitor |
| 02/13/2008 | CN100368404C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 02/13/2008 | CN100368398C 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 02/12/2008 | US7329765 Benzothiophene compounds having antiinfective activity |
| 02/12/2008 | US7329749 Piperazinylcarbonylquinolines and -isoquinolines |
| 02/12/2008 | US7329675 Substituted azabicyclic compounds |
| 02/12/2008 | US7329672 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329671 N2,N4-bis(3-hydroxyphenyl)-5-fluoro-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329670 downstream effector of p21ras oncogene; N-(1-(4-Methoxyphenyl)-3-tert-butyl-5-pyrazolyl)-N'-(2,3-dichlorophenyl)urea; antitumor, anticarcinogenic, antiproliferative agent; ras protein signal transduction cascade related cancer |
| 02/12/2008 | US7329661 N-phenyl-3-pyrimidine-amine derivatives |
| 02/12/2008 | US7329659 Substituted-1-phthalazinamines as vr-1 antagonists |
| 02/12/2008 | US7329657 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/12/2008 | US7329655 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent |
| 02/12/2008 | US7329652 Janus Kinase JAK2 and JAK3; 4-chloro-6-(3,5-dimethylpiperazin-1-yl)pyrimidine; chemotherapeutic, antiproliferative, antiinflammatory, immunomodulatory agent; allergies, asthma, autoimmune diseases, transplant rejection, rheumatoid arthritis, multiple sclerosis |
| 02/12/2008 | CA2208672C Immunotherapeutic imides/amides and their use for reducing levels of tnf.alpha. |
| 02/07/2008 | WO2008017079A2 Dyes and precursors and conjugates thereof |
| 02/07/2008 | WO2008017074A2 Dyes and precursors and conjugates thereof |
| 02/07/2008 | WO2008017020A2 Process for preparing proton pump inhibitors |
| 02/07/2008 | WO2008016811A2 Aminopiperidines and realted compounds |
| 02/07/2008 | WO2008015335A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 02/07/2008 | WO2008015250A1 Pyrimidine compounds for combating pathogenic fungi and cancer |
| 02/07/2008 | WO2008015189A2 Fungicidal n-cycloalkyl-carboxamide derivatives |
| 02/07/2008 | WO2008015125A1 1h-indol-6-yl-piperazin-1-yl-methanone-derivatives for use as h3 receptor modulators |
| 02/07/2008 | WO2008014822A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
| 02/07/2008 | WO2008014613A1 Multifunctional bioactive compounds |
| 02/07/2008 | WO2007136300A3 Substituted indoles and a method for the production and use thereof |
| 02/07/2008 | WO2007127375A3 Formulations containing pyridazine compounds for treating neuroinflammatory diseases |
| 02/07/2008 | WO2007098826A3 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 02/07/2008 | WO2007070506B1 Diaza heterocyclic sulfonamide derivatives and their uses |
| 02/07/2008 | US20080033179 Exhibit performance properties suited to high-speed optical recording applications; industrial scale; cyanine dyes; indole dyes; cationic dyes; low heat decomposition temperatures |
| 02/07/2008 | US20080033172 Mutagenic Heterocycles |
| 02/07/2008 | US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders |
| 02/07/2008 | US20080032997 (5S)-5-methyl-5-({[6-[2-(trifluoromethyl)pyrimidin-5-yl]-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)imidazolidine-2,4-dione; asthma, rhinitis, chronic obstructive pulmonary diseases (COPD), arthritis (such as rheumatoid arthritis and osteoarthritis), atherosclerosis, cancer |
| 02/07/2008 | US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative |
| 02/07/2008 | US20080032994 adducts of 2,6-di-tert-butyl-4-methylphenol (BHT) with azole compounds, e.g. ketoconazole, itraconazole, pramiconazole; skin fungal disorder associated with Trichophyton, Candida, Pityrosporum or Malassezia, or bacterial disorder associated with Staphylococci, Streptococci or Propionbacterium acnes |
| 02/07/2008 | US20080032980 1-Carbonyl-3,5-diphenyl-4,5-dihydro-1H-pyrazoles such as 1-acetyl-4-(1-{[3-(2,5-difluorophenyl)-5-methyl-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl]carbonyl}propyl)piperazine trifluoroacetate that are useful for treating cancer |
| 02/07/2008 | US20080032975 Substituted Fused Pyrroleoximes and Fused Pyrazoleoximes |
| 02/07/2008 | US20080032974 Compounds and therapeutical use thereof |
| 02/07/2008 | US20080032968 New compounds |
| 02/07/2008 | US20080032967 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase |
| 02/07/2008 | US20080032960 PI3 kinase antagonists |
| 02/07/2008 | US20080028542 New Reactive Dyes |
| 02/07/2008 | CA2659875A1 Multifunctional bioactive compounds |
| 02/07/2008 | CA2659696A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
| 02/07/2008 | CA2658911A1 Pyrimidine compounds for combating pathogenic fungi and cancer |
| 02/07/2008 | CA2658799A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 02/07/2008 | CA2658479A1 Novel hiv reverse transcriptase inhibitors |
| 02/07/2008 | CA2658282A1 1h-indol-6-yl-piperazin-1-yl-methanone-derivatives for use as h3 receptor modulators |
| 02/06/2008 | EP1884240A1 Pharmaceutical for prevention or treatment of bone metabolic disease |
| 02/06/2008 | EP1883632A1 Vanilloid receptor ligands and their use in treatments |
| 02/06/2008 | EP1883630A2 Methods of synthesizing 6-alkylaminoquinoline derivatives |
| 02/06/2008 | EP1883627A1 Bir domain binding compounds |
| 02/06/2008 | EP1883404A1 P38 inhibitors and methods of use thereof |
| 02/06/2008 | CN101119996A Chemical compouns |
| 02/06/2008 | CN101119988A Chemical compouns |
| 02/06/2008 | CN101119973A 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors |
| 02/06/2008 | CN101119968A Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 02/06/2008 | CN101119967A Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique |
| 02/06/2008 | CN100366616C Novel bicyclic inhibitors of hormone sensitive lipase |
| 02/06/2008 | CN100366610C Cyanine compound, optical recording material, and optical recording medium |
| 02/05/2008 | US7326793 From a pyrrolidinone compound; coloring high molecular weight material |
| 02/05/2008 | US7326791 Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions |
| 02/05/2008 | US7326714 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |